Motoharu Hamatake - Publications

Pulmonary-to-systemic flow ratio: lung cancer with partial anomalous pulmonary venous return.

Journal: General thoracic and cardiovascular surgery

Published: January 07, 2026

Investigation of the Biological Properties of Non-small Cell Lung Cancer Using Three-dimensional Computed Tomography Images.

Journal: Cancer diagnosis & prognosis

Published: March 21, 2025

Controlling nutritional status predicts postoperative survival and acute exacerbation in resected non-small cell lung cancer with interstitial lung disease.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 02, 2025

Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?

Journal: Annals of surgical oncology

Published: October 15, 2024

Impact of timing and initial recurrence site on post-recurrence survival in resected non-small cell lung cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 13, 2024

Prognostic Impact of Central Nervous System Recurrence After Surgery in Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer.

Journal: Anticancer research

Published: May 29, 2023

Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer?

Journal: Thoracic cancer

Published: March 18, 2023

Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.

Journal: Thoracic cancer

Published: August 08, 2022

Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 06, 2022

A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years).

Journal: International journal of clinical oncology

Published: November 29, 2021

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors.

Journal: PloS one

Published: November 02, 2021

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study.

Journal: JTCVS open

Published: September 16, 2021